-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FzHSIU5mbAqzJRMOGxYLce5/SIPn4EUD9Yc5ltRIXrm0sXb1fbTLqf9R1WP6xXKC CE9HM8asTO5fckZ/Hl/6kA== 0001193125-06-076728.txt : 20060410 0001193125-06-076728.hdr.sgml : 20060410 20060410142843 ACCESSION NUMBER: 0001193125-06-076728 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060410 DATE AS OF CHANGE: 20060410 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HUMAN PHEROMONE SCIENCES INC CENTRAL INDEX KEY: 0000878616 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 943107202 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-50071 FILM NUMBER: 06750506 BUSINESS ADDRESS: STREET 1: 84 WEST SANTA CLARA STREET STREET 2: SUITE 720 CITY: SAN JOSE STATE: CA ZIP: 95113 BUSINESS PHONE: 4089383030 FORMER COMPANY: FORMER CONFORMED NAME: EROX CORP DATE OF NAME CHANGE: 19940307 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SCHATZ LARRY H CENTRAL INDEX KEY: 0001259712 FILING VALUES: FORM TYPE: SC 13D MAIL ADDRESS: STREET 1: 903 PARK AVENUE #8E CITY: NEW YORK STATE: NY ZIP: 10021 SC 13D 1 dsc13d.htm SCHEDULE 13D Schedule 13D

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934

 

 

 

Human Pheromone Sciences, Inc.

(Name of Issuer)

 

 

Common Stock

(Title of Class of Securities)

 

 

44485Q203

(CUSIP Number)

 

 

  Copies to:

Larry H. Schatz

152 W. 57th Street

31st Floor

New York, New York 10019

(212) 554-0452

  

Joel M. Handel, Esq.

Brown Raysman Millstein Felder & Steiner LLP

900 Third Avenue

New York, New York 10022

(212) 895-2000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

 

March 30, 2006

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box  ¨.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent.

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 44485Q203

  

Page 2 of 5 Pages

 

  1.  

NAME OF REPORTING PERSONS:

 

Larry H. Schatz

    
  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ¨

(b)  ¨

    
  3.  

SEC USE ONLY

 

    
  4.  

SOURCE OF FUNDS

 

PF

    
  5.  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

 

   ¨
  6.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States

    

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

  

  7.    SOLE VOTING POWER

 

       300,000 shares

 

  8.    SHARED VOTING POWER

 

       -0- shares

 

  9.    SOLE DISPOSITIVE POWER

 

       300,000 shares

 

10.    SHARED DISPOSITIVE POWER

 

       -0- shares

11.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

300,000 shares

    
12.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

   ¨
13.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

7.225%

    
14.  

TYPE OF REPORTING PERSON

 

IN

    

 

CUSIP No. 44485Q203

  

Page 3 of 5 Pages

 

ITEM 1. SECURITY AND ISSUER

The title of the equity securities to which this statement relates is Common Stock (the “Issuer Common Stock”), of Human Pheromone Sciences, Inc., a California corporation (the “Issuer”). The principal executive office of the Issuer is located at 84 West Santa Clara Street, Suite 720, San Jose, California 95113.

 

ITEM 2. IDENTITY AND BACKGROUND

(a) This statement is filed by Larry H. Schatz (the “Reporting Person”).

(b) The principal business address of the Reporting Person is 152 East 57th Street, 31st Floor, New York, New York, 10019.

(c) The present principal occupation or employment of the Reporting Person is as an attorney in private practice.

(d) During the last five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

(e) During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f) The Reporting Person is a United States citizen.

 

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

The Reporting Person made the following purchases between March 30, 2006 and April 7, 2006:

 

Purchase Date

    Number of
Shares		    Price Per
Share		    Aggregate
Purchase Price

03/30/2006

    55,000    $ 0.2236    $ 12,573.00

04/04/2006

    5,000    $ 0.20    $ 1,010.99

04/05/2006

    5,000    $ 0.25    $ 1,260.99

04/05/2006

    5,000    $ 0.24    $ 1,210.99

04/06/2006

    5,000    $ 0.22    $ 1,110.99

04/07/2006

    10,000    $ 0.17    $ 1,721.98

04/07/2006

    8,000    $ 0.22    $ 1,775.83

TOTAL

    93,000       $ 20,664.77

The purchases were made on the open market through a broker-dealer. The source of the funds used in making such purchases was the Reporting Person’s personal funds.

CUSIP No. 44485Q203

  

Page 4 of 5 Pages

 

ITEM 4. PURPOSE OF TRANSACTION

The Issuer Common Stock owned by the Reporting Person was acquired for investment purposes. The Reporting Person may make additional investments in the Company through additional open market purchases.

Except as set forth in this statement, the Reporting Person does not presently have any plans or proposals that relate to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

 

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER

(a) The Reporting Person is the beneficial owner of an aggregate of 300,000 shares of Issuer Common Stock, which constitute approximately 7.225% of the Issuer Common Stock issued and outstanding as of the date hereof.

(b) See Rows 7 and 9 of the Cover Page.

(c) The information with respect to the acquisitions by Reporting Person, as set forth in Item 3, is hereby incorporated by reference.

(d) Not applicable.

(e) Not applicable.

 

ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER

None.

 

ITEM 7. MATERIAL TO BE FILED AS EXHIBITS

None.

CUSIP No. 44485Q203

  

Page 5 of 5 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: April 10, 2006

 

/s/ Larry H. Schatz

Larry H. Schatz

 -----END PRIVACY-ENHANCED MESSAGE-----